| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 126,867 | 127,504 | 128,494 | 160,039 | | Cost of Revenue | (257,391) | 119,012 | 138,379 | 167,495 | | | Gross Profit | 384,258 | 8,492 | (9,885) | (7,456) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 370,280 |
-
|
-
|
-
| | Non Recurring | 20,000 | 1,749 | 80,940 | 14,145 | | Others | 10,883 | 11,287 | 12,160 | 12,986 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (16,905) | (4,544) | (102,985) | (34,587) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 242 | (702) | 822 | (629) | | Earnings Before Interest And Taxes | (16,663) | (5,246) | (102,163) | (35,216) | | Interest Expense | 211 | 291 | 300 | 745 | | Income Before Tax | (16,874) | (5,537) | (102,463) | (35,961) | | Income Tax Expense | (11,109) | 1,534 | 605 | (2,831) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,765) | (7,071) | (103,068) | (33,130) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,765) | (7,071) | (103,068) | (33,130) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,765) | ($7,071) | ($103,068) | ($33,130) |
|
0.35% Nasdaq 
Income Statement
